-
公开(公告)号:US11708590B2
公开(公告)日:2023-07-25
申请号:US16631232
申请日:2018-07-16
发明人: David Nielsen , Brian Thompson
CPC分类号: C12P7/46 , C12N9/0069 , C12N9/0073 , C12N9/88 , C12N9/90 , C12P7/22 , C12Y113/11001 , C12Y114/13002 , C12Y114/13007 , C12Y401/01061 , C12Y401/01063 , C12Y401/01091 , C12Y401/0304 , C12Y401/99002 , C12Y402/0101 , C12Y402/99021 , C12Y504/04002
摘要: Certain embodiments provide a method for preparing a biochemical product (e.g., phenol, catechol, or muconic acid, or a salt thereof). For example, such methods include contacting a recombinant host having two or more recombinant pathways with a fermentable carbon source and growing the recombinant cell for a time sufficient to synthesize the product. In certain embodiments, each recombinant pathway: 1) is capable of producing the same final biochemical product; 2) comprises at least one gene encoding a polypeptide; 3) is derived from a different endogenous metabolite as its immediate precursor; and 4) converges to the same final product or the same intermediate metabolite.
-
公开(公告)号:US20230227799A1
公开(公告)日:2023-07-20
申请号:US18047589
申请日:2022-10-18
发明人: Andrew John Heron , James Anthony Clarke , Ruth Moysey , Elizabeth Jayne Wallace , Mark John Bruce , Lakmal Jayasinghe , Domenico Caprotti , Szabolcs Soeroes , Luke McNeill , David Antoni Alves , Rebecca Victoria Bowen , John Milton
IPC分类号: C12N9/14 , C12N9/90 , C12Q1/6827
CPC分类号: C12N9/14 , C12Y306/04012 , C12N9/90 , C12Y599/01003 , C12Y599/01002 , C12Q1/6827 , C07K2319/80
摘要: The invention relates to modified helicases with reduced unbinding from polynucleotides. The helicases can be used to control the movement of polynucleotides and are particularly useful for sequencing polynucleotides.
-
公开(公告)号:US20230212624A1
公开(公告)日:2023-07-06
申请号:US18018360
申请日:2021-07-29
申请人: Givaudan SA
发明人: Jean-Pierre BARRAS , Sylvie MOREL , Eric EICHHORN
CPC分类号: C12P17/04 , C12N9/90 , C12Y504/99017
摘要: A method for purifying a crude flavor or perfumery or cosmetic ingredient or intermediate, for example crude (−)-Ambrox, comprising a number of washing steps, the products of said method, and uses of said product.
-
34.
公开(公告)号:US20230212254A1
公开(公告)日:2023-07-06
申请号:US17904221
申请日:2021-02-15
发明人: Hoeon KIM , Choonju JEON , Yu WANG , Namchul JUNG
IPC分类号: C07K14/725 , C12N5/0783 , C12N15/86 , C12N9/90 , A61K35/17 , C07K14/705 , C07K14/435 , C07K14/005 , C07K14/47 , A61P35/02
CPC分类号: C07K14/7051 , A61K35/17 , A61P35/02 , C07K14/005 , C07K14/435 , C07K14/4748 , C07K14/70503 , C07K14/70517 , C07K14/70578 , C07K14/70596 , C12N5/0636 , C12N9/90 , C12N15/86 , C07K2317/53 , C07K2317/622 , C07K2319/02 , C07K2319/03 , C07K2319/72 , C12N2740/15043 , C12N2740/15071
摘要: The present invention relates to an immune cell that are engineered to overexpress cell signaling pathway modulator(s) and a use thereof. As a specific example, an immune cell expressing a fusion protein comprising a chimeric antigen receptor and a cell signaling pathway modulator(s) performs an immune response by selecting a target cancer cell by a chimeric antigen receptor expressed on a cell membrane. In this case, the cell signaling pathway modulator is overexpressed in the cytoplasm, thereby being capable of regulating the activity of an immune cell. Therefore, the fusion protein comprising a chimeric antigen receptor and cell signaling pathway modulator(s), and the immune cell engineered to overexpress the cell signaling pathway modulator(s) of the present invention can be usefully used in the treatment of cancer.
-
公开(公告)号:US20230183671A1
公开(公告)日:2023-06-15
申请号:US17926032
申请日:2021-06-04
CPC分类号: C12N9/90 , C07K1/10 , C12Y503/04001
摘要: An object to be achieved by the present in is to prepare a droplet using a protein that has not been known heretofore to form a droplet. The present invention provides a droplet including an assembly of a protein, wherein the protein is a PDI family protein and/or an artificial protein, and contains a thioredoxin-like domain.
-
公开(公告)号:US20230175027A1
公开(公告)日:2023-06-08
申请号:US17995512
申请日:2021-04-14
申请人: Givaudan SA
发明人: Eric EICHHORN , Felix FLACHSMANN , Andreas GOEKE
CPC分类号: C12P17/181 , C12N9/90 , C12Y504/99017 , C11B9/008
摘要: An enzyme-mediated method for the production of Amberketal and Amberketal homologues, the products of said method, and uses of said products.
-
37.
公开(公告)号:US20230174960A1
公开(公告)日:2023-06-08
申请号:US17926208
申请日:2021-05-20
申请人: MEIOGENIX , INSTITUT CURIE , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE , SORBONNE UNIVERSITE
发明人: ALEXANDRE SERERO , ALAIN NICOLAS
CPC分类号: C12N9/22 , C12N9/90 , C12N15/63 , C12N2310/20
摘要: The present invention relates to a fusion protein comprising a domain of a nuclease from the class II CRISPR system, and a Spo11 domain, wherein both domains of the fusion protein have deficient nuclease activity, as well as the use of this protein to induce targeted meiotic recombinations in a eukaryotic cell.
-
公开(公告)号:US20230159941A1
公开(公告)日:2023-05-25
申请号:US17297727
申请日:2020-01-13
发明人: Heiko DIETZ , Magdalena MERTEL , Jörg CLAREN , Alexander FARWICK
摘要: The present invention comprises a chimeric promoter which initiates the transcription of a gene depending on different conditions such as carbon sources. Further the invention relates to a recombinant DNA fragment comprising the chimeric promoter, an expression plasmid comprising the recombinant DNA fragment and a host cell transformed with the recombinant DNA fragment.
-
公开(公告)号:US20190211342A1
公开(公告)日:2019-07-11
申请号:US16362897
申请日:2019-03-25
发明人: Ron MILO , Niv ANTONOVSKY , Elad NOOR , Arren BAR-EVEN , Yehudit ZOHAR , Lior ZELCBUCH , Shmuel GLEIZER , Shira AMRAM
IPC分类号: C12N15/70 , C07K14/195 , C12N9/04 , C12N9/10 , C12N9/12 , C12N9/88 , C12N9/90 , C07K14/245 , C12N1/20
CPC分类号: C12N15/70 , C07K14/195 , C07K14/245 , C12N1/20 , C12N9/0006 , C12N9/1025 , C12N9/1205 , C12N9/88 , C12N9/90 , C12Y101/01049 , C12Y203/03009 , C12Y207/01011 , C12Y207/01019 , C12Y401/01039 , C12Y402/01011 , C12Y504/02
摘要: A microorganism which is genetically modified so that it produces a first essential biomass precursor by metabolizing CO2 using a recombinant carbon fixation enzyme is disclosed. The microorganism produces a second biomass precursor by metabolizing an organic carbon source and not by metabolizing CO2. The microorganism does not use the organic carbon source for producing the first essential biomass precursor.
-
公开(公告)号:US20190194699A1
公开(公告)日:2019-06-27
申请号:US16230932
申请日:2018-12-21
发明人: Eduardo Esteban Agosin Trumper , Francisco Javier Saitua Perez , Javiera Cecilia Lopez Salinas , Maciej E Domaradzki , Maximiliano Ibaceta Acevedo , Natalia Arenas Frigolett
CPC分类号: C12P7/26 , C12N9/0069 , C12N9/1085 , C12N9/90 , C12N15/52 , C12N15/81 , C12Y113/11071 , C12Y205/01029 , C12Y505/01018
摘要: This invention provides improved biological synthesis of the apocarotenoid α-ionone in Saccharomyces cerevisiae. The final native step involved in the natural apocarotenoid pathway depends on an endogenous farnesyl pyrophosphate synthase (FPPs). From there, heterologous geranylgeranyl pyrophosphate synthase (crtE), phytoene synthase (crtB), phytoene desaturase (crtI), lycopene ε-cyclase (LycE) and a Carotenoid Cleavage Dioxygenase (CCD1) are required to complete the synthesis of α-ionone. Lycopene ε-cyclase from lettuce (Lactuca sativa) or modified cyclase from Arabidopsis thaliana was used to overproduce lycopene which was then cleaved by the carotenoid cleavage dioxygenase from Petunia hybrida (Ph-CCD1).
-
-
-
-
-
-
-
-
-